{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:52:04Z","timestamp":1791089524060,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.drugalcdep.2012.11.011","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:45:11Z","timestamp":1355273111000},"page":"187-193","source":"Crossref","is-referenced-by-count":13,"title":["Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls"],"prefix":"10.1016","volume":"128","author":[{"given":"Vassilis N.","family":"Panagopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Trull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Glowinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Lynskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpana","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali K.","family":"Henders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre A.","family":"Todorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.F.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant W.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archpsyc.65.6.713","article-title":"An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project","volume":"65","author":"Agrawal","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSMIV-TR","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1037\/a0018095","article-title":"Borderline personality disorder: a dysregulation of the endogenous opioid system?","volume":"117","author":"Bandelow","year":"2010","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1521\/pedi.18.3.226.35445","article-title":"Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention","volume":"18","author":"Black","year":"2004","journal-title":"J. Pers. Disord."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15288\/jsa.1994.55.149","article-title":"A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA","volume":"55","author":"Bucholz","year":"1994","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0035","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1360-0443.2007.01876.x","article-title":"Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence","volume":"102","author":"Darke","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1360-0443.2005.01123.x","article-title":"The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence","volume":"100","author":"Darke","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0045","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ng1669","article-title":"Efficiency and power in genetic association studies","volume":"37","author":"de Bakker","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tins.2005.11.003","article-title":"Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function","volume":"29","author":"Dean","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0055","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1017\/S0033291707002024","article-title":"Heritability of borderline personality disorder features is similar across three countries","volume":"38","author":"Distel","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1601-183X.2012.00815.x","article-title":"Association of neurexin 3 polymorphisms with smoking behavior","volume":"11","author":"Docampo","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0065","first-page":"359","article-title":"Personality disorders and completed suicide: a methodological and conceptual review","volume":"4","author":"Duberstein","year":"1997","journal-title":"Clin. Psychol. (NY)"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11920-010-0168-9","article-title":"State of the art in the pharmacologic treatment of borderline personality disorder","volume":"13","author":"Feurino","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archgenpsychiatry.2011.37","article-title":"Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study","volume":"68","author":"Gunderson","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0080","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1046\/j.1360-0443.1999.94913618.x","article-title":"A validity study of the SSAGA\u2014a comparison with the SCAN","volume":"94","author":"Hesselbrock","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0085","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1093\/hmg\/ddm247","article-title":"Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms","volume":"16","author":"Hishimoto","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s001270050276","article-title":"Personality disorders in the community: a report from the Australian National Survey of Mental Health and Wellbeing","volume":"35","author":"Jackson","year":"2000","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0095","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0033291706007288","article-title":"A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients","volume":"36","author":"Joyce","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0100","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/archpsyc.65.12.1438","article-title":"The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study","volume":"65","author":"Kendler","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12035-011-8213-1","article-title":"Neurexins and neuroligins: recent insights from invertebrates","volume":"44","author":"Knight","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.conb.2012.02.012","article-title":"The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses","volume":"22","author":"Krueger","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0115","series-title":"A Research Agenda for DSM-V.","year":"2002"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/hmg\/ddm081","article-title":"Genomewide suggestive linkage of opioid dependence to chromosome 14q","volume":"16","author":"Lachman","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(10)61422-5","article-title":"Borderline personality disorder","volume":"377","author":"Leichsenring","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00127-005-0878-1","article-title":"Assessing personality disorders in a national mental health survey","volume":"40","author":"Lewin","year":"2005","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0135","doi-asserted-by":"crossref","first-page":"11864","DOI":"10.1073\/pnas.0500329102","article-title":"Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples","volume":"102","author":"Liu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archpsyc.1994.03950030051005","article-title":"The international personality disorder examination: the world health organization\/alcohol, drug abuse, and mental health administration international pilot study of personality disorders","volume":"51","author":"Loranger","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.psychres.2008.06.026","article-title":"Impulsivity and borderline personality as risk factors for suicide attempts among opioid-dependent individuals","volume":"169","author":"Maloney","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eurpsy.2009.05.001","article-title":"The serotonin transporter gene polymorphism (5-HTTLPR) and affective symptoms among women diagnosed with borderline personality disorder","volume":"25","author":"Maurex","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0155","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jpsychires.2009.01.002","article-title":"Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder","volume":"43","author":"McCloskey","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0160","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/jclp.1105","article-title":"Predictors of deterioration among patients with substance-use disorders","volume":"57","author":"Moos","year":"2001","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0165","doi-asserted-by":"crossref","DOI":"10.1111\/j.1369-1600.2012.00445.x","article-title":"Association of OPRD1 polymorphisms with heroin dependence in a large case-control series","author":"Nelson","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-9081-6-4","article-title":"Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients","volume":"6","author":"Nemoda","year":"2010","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0175","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1176\/appi.ajp.2010.10040634","article-title":"An opioid deficit in borderline personality disorder: self-cutting, substance abuse, and social dysfunction","volume":"167","author":"New","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpsychires.2006.03.010","article-title":"Association between serotonin transporter gene and borderline personality disorder","volume":"40","author":"Ni","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0185","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1371\/journal.pgen.0020190","article-title":"Population structure and eigenanalysis","volume":"2","author":"Patterson","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0190","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0195","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jpsychires.2010.03.014","article-title":"Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls","volume":"44","author":"Perez-Rodriguez","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0200","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ajmg.b.30741","article-title":"Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes","volume":"147B","author":"Peters","year":"2008","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0205","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1176\/appi.ajp.2010.09091348","article-title":"Dysregulation of regional endogenous opioid function in borderline personality disorder","volume":"167","author":"Prossin","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2012.11.011_bib0215","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/mpr.209","article-title":"Dimensional approaches to psychiatric classification: refining the research agenda for DSM-V: an introduction","volume":"16","author":"Regier","year":"2007","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0220","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/513703","article-title":"Genetic linkage to chromosome 22q12 for a heavy-smoking quantitative trait in two independent samples","volume":"80","author":"Saccone","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2190\/PM.38.2.h","article-title":"The prevalence of borderline personality among buprenorphine patients","volume":"38","author":"Sansone","year":"2008","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addbeh.2010.08.008","article-title":"Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence","volume":"36","author":"Shand","year":"2011","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0235","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0006-3223(02)01326-4","article-title":"The borderline diagnosis III: identifying endophenotypes for genetic studies","volume":"51","author":"Siever","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1176\/appi.ajp.159.2.276","article-title":"Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder","volume":"159","author":"Skodol","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0245","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0006-3223(02)01324-0","article-title":"The borderline diagnosis I: psychopathology, comorbidity, and personaltity structure","volume":"51","author":"Skodol","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0250","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.paid.2009.04.008","article-title":"Fifty years of the Barratt Impulsiveness Scale: an update and review","volume":"47","author":"Stanford","year":"2009","journal-title":"Pers. Individ. Dif."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1176\/appi.ajp.2009.09050744","article-title":"The interpersonal dimension of borderline personality disorder: toward a neuropeptide model","volume":"167","author":"Stanley","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0260","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.drugalcdep.2011.05.025","article-title":"Associations among types of impulsivity, substance use problems and neurexin-3 polymorphisms","volume":"119","author":"Stoltenberg","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0265","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature07456","article-title":"Neuroligins and neurexins link synaptic function to cognitive disease","volume":"455","author":"S\u00fcdhof","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0270","series-title":"The American Psychiatric Publishing Textbook of Personality Disorders","first-page":"129","article-title":"Epidemiology","author":"Torgersen","year":"2005"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0275","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1017\/S0033291708002924","article-title":"Dimensional representations of DSM-IV cluster B personality disorders in a population-based sample of Norwegian twins: a multivariate study","volume":"38","author":"Torgersen","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0280","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/comp.2000.16560","article-title":"A twin study of personality disorders","volume":"41","author":"Torgersen","year":"2000","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0272-7358(99)00028-8","article-title":"Borderline personality disorder and substance use disorders: a review and integration","volume":"20","author":"Trull","year":"2000","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0290","doi-asserted-by":"crossref","unstructured":"Trull, T.J., Solhan, M.B., Brown, W.C., Tomko, R.L., Schaefer, L., Jahng, S. Substance use disorders and personality disorders. In: Sher, K. (Ed.), Handbook of Substance Use Disorders. Oxford University Press, Oxford, New York, in press.","DOI":"10.1093\/oxfordhb\/9780199381708.013.15"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0295","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.neubiorev.2007.11.003","article-title":"Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies","volume":"32","author":"Verdejo-Garc\u00eda","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajmg.b.30788","article-title":"The tryptophan hydroxylase-1 A218C polymorphism is associated with diagnosis, but not suicidal behavior, in borderline personality disorder","volume":"150B","author":"Wilson","year":"2009","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0305","series-title":"ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organisation (WHO)","year":"1992"},{"key":"10.1016\/j.drugalcdep.2012.11.011_bib0310","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1360-0443.2010.03176.x","article-title":"The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study","volume":"106","author":"Zanarini","year":"2011","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612004528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612004528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:20:22Z","timestamp":1540023622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612004528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0376871612004528"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.11.011","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}